|
Selected Presentations
2000 Rhode Island Cancer Council Forum on “Successful Survivorship After Cancer”. Invited Speaker on “Continuing Healthcare After Successful Cancer Treatment”, Warwick, RI
2002 International Symposium on Advanced Tumor Prevention & Therapy; Invited Speaker on “Hodgkin’s Disease: Current Treatment and Late Effects”, Jinan, Shandong, China
2003 Recruiting high risk women into randomised intervention trials in the US”, Invited Speaker, Christie Hospital, Manchester UK
2003 Improving Survival and Quality of Life of Long-Term Survivors of Hodgkin’s Disease”. Invited Speaker, The Rockefellar Foundation Bellagio Study and Conference Center, Lake Como, Italy
2004 Hodgkin Lymphoma Late Effect Study Group. Invited Speaker on “A Prospective Cardiac Screening Study in Survivors of Hodgkin’s Disease”, The 6th International Symposium on Hodgkin's Disease, Cologne, Germany
2004 NCI Second Cancers workshop “Cancer Survivorship: Genetic Susceptibility and Second Primary Cancers”. Invited Speaker on “Current Work in Second Primary Cancers and Other Late Effects of Hodgkin’s Disease”, Bethesda, MD
2006 Visiting Professor at Cleveland Clinic, Department of Radiation Oncology, Cleveland, OH
2006 Cancer Survivor Research and Education, CURED I Meeting. Invited Speaker on “Breast MRI Screening for Female Survivors of Hodgkin’s Disease”, Rochester, NY
2006 ASTRO Panel on “Cancer Survivorship”, Co-Chair, Philadelphia, PA
2007 ASCO Educational Session on “Survivors of Hodgkin’s Disease: the Evolving Picture of Cancer Care”. Invited Speaker, Chicago, IL
2007 Hodgkin Lymphoma Cancer Survivorship Workshop. Invited Speaker on “Breast MRI Screening for Survivors of Hodgkin’s Disease”, The 7th International Symposium on Hodgkin's Disease, Cologne, Germany
Selected Publications:
Ng AK, Bernardo MP, Weller E, et al. Second Malignancy After Hodgkin’s Disease: Long-Term Risk and Risk Factors. Blood 100:1989-1996, 2002
Ng AK and Mauch PM. Second Malignancy After Hodgkin’s Disease. The American Journal of Oncology Review 2003; 2:190-2003
Ng AK, Mauch PM. Late Complications of Therapy of Hodgkin's Disease-Prevention and Management. Current Hematology Reports 2004; 3(1):27-33
Mauch P, Ng A, Aleman B, et al. “Report from the Rockefellar Foundation Sponsored Workshop on Reducing Mortality and Improving Quality of Life in Long-Term Survivors of Hodgkin’s Disease, Held July 9-16, 2003, Bellagio, Italy” Eur J Haematol 75 Suppl 66: p. 68, 2005
Travis LB, Rabkin CS, Brown LM, Allan JM, Alter BP, Ambrosone CB, Begg CB, Caporaso N, Chanock S, DeMichele A, Figg WD, Gospodarowicz MK, Hall EJ, Hisada M, Inskip P, Kleinerman R, Little JB, Malkin D, Ng AK, Offit K, Pui CH, Robison LL, Rothman N, Shields PG, Strong L, Taniguchi T, Tucker MA, Greene MH. Cancer Survivorship - Genetic Susceptibility and Second Primary Cancers: Research Strategies and Recommendations. JNCI 98:15-25. 2006
Ng AK, Mauch PM. The impact of treatment on the risk of second malignancy after Hodgkin's disease. Ann Oncol 17: 1727-1729, 2006
Friedberg JW and Ng, AK. “Epidemiology of Second Malignancies Following Lymphoma Therapy and Screening Recommendations” In: Sekeres MA, eds “Clinical Malignant Hematology”; 2007, p 815-822
Carver JR, Shapiro CL, Ng A, et al. American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects. J Clin Oncol 25:3991-4008, 2007
Ng AK, Travis LB. Second Malignant Neoplasms: An Overview. Hematology/Oncology Clinics of North America 22:271-289, 2008
|
Andrea Ng, Brigham and Women's Hospital